Unbiased Analysis of Today's Healthcare Issues
A paper by Hanson et al. (2023) summarizes the Congressional Budget Office’s projections around US health insurance coverage between 2023-2033. They find that low rates of uninsurance due to provisions enacted to combat COVID-19 will not be sustained as these provisions expire: Temporary policies enacted in response to the COVID-19 pandemic have increased Medicaid and…
That is the topic of a recent paper Tyan, Lam and Milligan (2023). Using newly created database from financial databases combined with press releases, news sources, clinic websites, and financial 10-K reports, the authors found that: During 2003 to 2022, 724 oncology clinics (53% radiation, 32% medical, 15% multi-oncologic) became affiliated with a PE-backed platform…
Some stats from Citeline’s Pharma R&D Annual Report 2023. And by company sorted by pipeline size as of January 2023:
A paper by Caraballo et al. (2023) published today uses CDC data to measure excess mortality among Black Americans between 1999-2020. They find that: From 1999 to 2011, the age-adjusted excess mortality rate declined from 404 to 211 excess deaths per 100 000 individuals among Black males (P for trend <.001). However, the rate plateaued from…
Results below from UNESCO data. Presented without commentary. HT: Marginal Revolution
A paper by Brady et al. (2023) aims to measure this relationship in the US. They use data from the 1997-2019 Panel Study of Income Dynamics (PSID) data merged with the Cross-National Equivalent File. The data were validated with information from the National Death Index. The authors adjust for self-reported health, demographics, comorbidities and a…
That is the questions Peter Neumann and David Kim (2023) answer in their JAMA research letter published today. They use 1990-2021 data from the Tufts Medical Center CEA Registry. The results are summarized in the graphs below. First, we see the use of a explicit cost effectiveness threshold increasing over time, from only 45% of…
Some troubling statistics published recently by Woolf et al. (2023) using CDC WONDER data: Between 2019 and 2020, the all-cause mortality rate for ages 1 to 19 years increased by 10.7%, and it increased by an additional 8.3% between 2020 and 202…These increases, the largest in decades, followed a period of great progress in reducing…
FDA’s Office of Generic Drugs issued their 2022 Annual Report. Generic drugs play a vital role in saving patients and payers money. To give an example, pregabalin capsules cost $450 for a 30-day supply during the end of its market exclusivity period, but priced dropped to $23 (a 95% decrease) during the first 12 months…
A study by the World Obesity Foundation predicts that more than half the global population will be living with overweight and obesity within 12 years if prevention, treatment and support do not improve. The report also predicts that the global economic burden of overweight and obesity will be $4.32 trillion or approximately 2.9% of global…